MDP1 is a motif-derived peptide with a defined arrangement of aromatic, polar, and basic residues supporting structured recognition. Researchers employ it for protein-binding studies, aggregation assays, and motif-function exploration. The sequence offers flexibility for engineering and mutational analysis. Applications include peptide-design research, structural biophysics, and interaction profiling.
CAT No: R2753
MDP1, known as Muramyl Dipeptide 1, is a synthetic dipeptide derivative that structurally mimics the minimal bioactive motif of bacterial peptidoglycan. As a peptide compound, it plays a pivotal role in immunological and microbiological research due to its capacity to interact with innate immune receptors, such as NOD2. Its defined structure and biological relevance have made it a valuable tool for dissecting host-pathogen interactions, innate immunity signaling, and the molecular mechanisms underlying immune recognition of bacterial components. The compound's stability and precise composition further facilitate its integration into a wide range of biochemical and cell-based experimental systems.
Innate Immunity Research: MDP1 is extensively utilized in studies exploring the activation of innate immune pathways, particularly those mediated by nucleotide-binding oligomerization domain-containing protein 2 (NOD2). By serving as a ligand for NOD2, the dipeptide enables researchers to model the cellular response to bacterial infection, elucidate downstream signaling cascades, and characterize the molecular basis of pathogen recognition in mammalian cells. Its use has proven critical in differentiating NOD2-dependent responses from those triggered by other pattern recognition receptors, thereby enhancing the specificity and interpretability of immunological assays.
Inflammation Pathway Analysis: In the context of inflammation biology, MDP1 supports investigations into the regulation of pro-inflammatory cytokine production and the modulation of intracellular signaling events. By stimulating immune cells with this dipeptide, scientists can probe the release of cytokines such as interleukin-1β and tumor necrosis factor-α, map the activation of NF-κB and MAPK pathways, and assess the contribution of bacterial cell wall fragments to inflammatory processes. These studies provide valuable insights into the molecular drivers of inflammatory diseases and innate immune dysregulation.
Adjuvant Mechanism Elucidation: The compound is frequently employed to dissect the mechanistic basis of adjuvant activity in vaccine research. Its ability to mimic the immune-stimulatory effects of natural bacterial components allows for systematic evaluation of how dipeptide motifs potentiate antigen-specific immune responses. By integrating MDP1 into adjuvant formulations or experimental immunization protocols, researchers can investigate the enhancement of antigen presentation, T cell activation, and the overall efficacy of immune potentiators, thereby advancing the rational design of next-generation adjuvants.
Host-Pathogen Interaction Models: MDP1 is a critical reagent in the development of in vitro and in vivo models that simulate host-pathogen dynamics. Its defined structure enables precise manipulation of experimental variables, facilitating the study of bacterial recognition, immune evasion strategies, and the interplay between microbial products and host defense mechanisms. Such models are essential for unraveling the complexities of infectious disease progression and for identifying novel targets for antimicrobial intervention.
Peptide Structure-Activity Relationship Studies: Owing to its well-characterized peptide sequence, MDP1 serves as a reference molecule in structure-activity relationship (SAR) analyses. Researchers utilize it to systematically modify amino acid residues or peptide linkages, thereby delineating the structural determinants of immune activation and receptor binding. These SAR studies inform the design of novel peptide agonists or antagonists with tailored biological activities, supporting both basic research and the development of innovative immunomodulatory agents.
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Myotropic activity of allatostatins in tenebrionid beetles
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More